Bjoern Chapuy

Genetic resistance to JAK2 enzymatic inhibitors is overcome by HSP90 inhibition

Eric Vangrevelinghe, Andrew L. Kung, James E. Bradner, 2011, The Journal of experimental medicine.

Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes

Stefano Monti, Gad Getz, Ignaty Leshchiner, 2018, Nature Medicine.

FBXO11 targets BCL6 for degradation and is inactivated in diffuse large B-cell lymphomas

Michele Pagano, Mario Rossi, M. Shipp, 2012, Nature.

Integrative analysis reveals an outcome-associated and targetable pattern of p53 and cell cycle deregulation in diffuse large B cell lymphoma.

Stefano Monti, Ahmet Dogan, Donna Neuberg, 2012, Cancer cell.

The pre-B-cell receptor associated protein VpreB3 is a useful diagnostic marker for identifying c-MYC translocated lymphomas

Randy D. Gascoyne, Claudio Agostinelli, Hiroaki Nitta, 2010, Haematologica.

Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing

Eric S. Lander, Petar Stojanov, Todd R. Golub, 2012, Proceedings of the National Academy of Sciences.